Management of heart failure in the Netherlands

被引:20
作者
Jaarsma, T [1 ]
Haaijer-Ruskamp, FM
Sturm, H
Van Veldhuisen, DJ
机构
[1] Univ Groningen, Med Ctr, Dept Cardiol, NL-9700 AB Groningen, Netherlands
[2] Univ Groningen, Inst Drug Explorat, Dept Clin Pharmacol, NL-9700 AB Groningen, Netherlands
关键词
heart failure; The Netherlands; diagnosis; treatment; disease management;
D O I
10.1016/j.ejheart.2005.01.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In The Netherlands, the incidence and prevalence of heart failure are rising as is the case in most other European countries. Overall, there are 200,000 patients with heart failure in The Netherlands and around 25,000 hospitalisations annually with a discharge diagnosis of heart failure. Most of these patients are managed in primary care, often together with a cardiologist. There is an active guideline program in different professional organisations (e.g. general practitioners, cardiologists) and in 2002 a collaborative multidisciplinary guideline for management of chronic heart failure was developed. However, there is clearly room for improvement in the adherence to these guidelines both with regard to the diagnosis and the treatment of HF patients. For example, ACE-I and beta-blockers are still under-prescribed. In particular, the more severely ill patients seem to be under treated. At present, general practitioners and cardiologists differ in their views on heart failure, resulting in differences in diagnosis and management. In addition to the multidisciplinary guidelines, several other initiatives have been developed to improve outcomes in these patients, such as rapid access clinics and outpatient heart failure clinics. (C) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 30 条
[1]   The relative contribution of domains of quality of life to overall quality of life for different chronic diseases [J].
Arnold, R ;
Ranchor, AV ;
Sanderman, R ;
Kempen, GIJM ;
Ormel, J ;
Suurmeijer, TPBM .
QUALITY OF LIFE RESEARCH, 2004, 13 (05) :883-896
[2]   Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure - The Rotterdam Study [J].
Bleumink, GS ;
Knetsch, AM ;
Sturkenboom, MCJM ;
Straus, SMJM ;
Hofman, A ;
Deckers, JW ;
Witteman, JCM ;
Stricker, BHC .
EUROPEAN HEART JOURNAL, 2004, 25 (18) :1614-1619
[3]   Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: A randomized controlled study [J].
Bouvy, ML ;
Heerdink, ER ;
Urquhart, J ;
Grobbee, DE ;
Hoe, AW ;
Leufkens, HGM .
JOURNAL OF CARDIAC FAILURE, 2003, 9 (05) :404-411
[4]  
BRASPENNING J, 2004, INDICATOREN MED TECH
[5]   Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey [J].
Cleland, JGF ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Eastaugh, J ;
Follath, F ;
Freemantle, N ;
Gavazzi, A ;
van Gilst, WH ;
Hobbs, FDR ;
Korewicki, J ;
Madeira, HC ;
Preda, I ;
Swedberg, K ;
Widimsky, J .
LANCET, 2002, 360 (9346) :1631-1639
[6]   The management of heart failure in Sweden [J].
Cline, CMJ ;
Boman, K ;
Holst, M ;
Erhardt, LR .
EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :373-376
[7]   The management of patients with heart failure in France [J].
Cohen-Solal, A ;
Bouhour, JB ;
Thebaut, JF .
EUROPEAN JOURNAL OF HEART FAILURE, 2000, 2 (02) :223-226
[8]  
DELOOR S, 2002, EUR J CARDIOVASC NUR, V1, P123
[9]   Auditing GPs' prescribing habits: Cardiovascular prescribing frequently continues medication initiated by specialists [J].
deVries, CS ;
vanDiepen, NM ;
Tromp, TFJ ;
deJongvandenBerg, LTW .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 50 (05) :349-352
[10]  
Hoes A. W., 1998, European Heart Journal, V19, pL2